Malcolm MacLeod | IR |
Philip Taylor | Gilmartin Group |
John Sperzel | Chairman and CEO |
John Sprague | CFO |
Brett Giffin | Chief Commercial Officer |
Benjamin Haynor | Alliance Global Partners |
Stephen Brozak | WBB |
Good day, ladies and gentlemen, and welcome to the T2 Biosystems First Quarter 2022 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Malcolm MacLeod. Sir, the floor is yours.
Thank you, operator.